Journal of Atherosclerosis and Thrombosis

Papers
(The H4-Index of Journal of Atherosclerosis and Thrombosis is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Impact of Changes in Lifestyle and Psychological Factors on the Incidence of Metabolic Syndrome after the Great East Japan Earthquake: Follow-up of the Fukushima Health Management Survey200
Association of Visceral Fat Accumulation with Endothelial Glycocalyx Degradation in People with and without Type 2 Diabetes: A Retrospective Cross-sectional Study128
Association between C-Reactive Protein Levels and Functional Disability in the General Older-Population: The Takashima Study96
Left Ventricular Abnormality and Covert Atrial Fibrillation in Embolic Stroke of Undetermined Source77
Progress in Pathological Diagnosis after Kidney Transplantation: Current Trend and Future Perspective73
MAFLD and Small Dense LDL Cholesterol: A Mechanistic Link43
Associations of Serum Insulin-Like Growth Factor 1 with New Cardiovascular Events and Subsequent Death in Hemodialysis Patients: The DREAM Cohort42
The Role of Polygenic Risk Score in the General Population: Current Status and Future Prospects36
Integrated Analysis of Two Probucol Trials for the Secondary Prevention of Atherosclerotic Cardiovascular Events: PROSPECTIVE and IMPACT35
Advances in Beyond Statin Lipid Therapies for ASCVD Risk Reduction35
Relationship between Kidney Function and Subclinical Atherosclerosis Progression Evaluated by Coronary Artery Calcification35
ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis34
Growth Differentiation Factor-15 and Clinical Outcomes in Lower Extremity Artery Disease30
<i>JAK2</i> V617F Mutation and Large Cerebral Artery Disease in Patients with Myeloproliferative Neoplasms30
Cholesterol Efflux Capacity and Anti-Oxidative Activity of High-Density Lipoprotein in Chronic Kidney Disease29
Atherosclerotic Diseases in Chronic Kidney Disease29
Phenotypic and Genetic Analyses of Korean Patients with Familial Hypercholesterolemia: Results from the KFH Registry 202028
<i>RNF213</i> p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden28
Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial28
Fish-Derived Omega-3 Fatty Acids: Guardians of High-Density Lipoprotein?24
Atrial Cardiomyopathy Predicts the Functional Outcome and Mortality in Stroke Patients24
The Blockade of Delta-Like Ligand 1 Inhibits Atherosclerotic Lesion Formation and Attenuates Plaque Vulnerability24
Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial23
Non–high-density Lipoprotein Cholesterol for Secondary Prevention after Minor Stroke23
0.25767803192139